Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
出版年份 2022 全文链接
标题
Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 12, Pages 6458
出版商
MDPI AG
发表日期
2022-06-10
DOI
10.3390/ijms23126458
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Platinum-based systematic therapy in triple-negative breast cancer
- (2022) Yinxing Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- HDAC Inhibitors: Innovative Strategies for Their Design and Applications
- (2022) Mateusz Daśko et al. MOLECULES
- Special Histologic Type and Rare Breast Tumors – Diagnostic Review and Clinico-Pathological Implications
- (2022) Benjamin Yongcheng Tan et al. Surgical Pathology Clinics
- Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy
- (2022) Dehua Lu et al. BIOORGANIC CHEMISTRY
- New and Emerging Targeted Therapies for Advanced Breast Cancer
- (2022) Kristie H. Lau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of histone demethylases and histone methyltransferases in triple-negative breast cancer: Epigenetic mnemonics
- (2022) Janice Jacson Mandumpala et al. LIFE SCIENCES
- Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
- (2022) Anna Wawruszak et al. Cells
- Role of Platinums in Triple-Negative Breast Cancer
- (2021) Filipa Lynce et al. Current Oncology Reports
- Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models
- (2021) Marta Hałasa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?
- (2021) Prihantono et al. Annals of Medicine and Surgery
- Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
- (2021) Hao Tian et al. Frontiers in Pharmacology
- Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies
- (2020) Sarwat Chowdhury et al. MOLECULES
- Emerging Role of Sirtuins in Breast Cancer Metastasis and Multidrug resistance: Implication for Novel Therapeutic Strategies Targeting Sirtuins
- (2020) Sonam Sinha et al. PHARMACOLOGICAL RESEARCH
- Epi-drugs as triple-negative breast cancer treatment
- (2020) Mouhamed Idrissou et al. Epigenomics
- Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
- (2019) Anna Wawruszak et al. Cancer Management and Research
- Isobologram Analysis: A Comprehensive Review of Methodology and Current Research
- (2019) Ruo-yue Huang et al. Frontiers in Pharmacology
- Epigenetic agents in combined anticancer therapy
- (2018) Zdeněk Kejík et al. Future Medicinal Chemistry
- Suivi thérapeutique pharmacologique du 5-fluorouracile : mise au point et recommandations du groupe STP-PT de la SFPT et du GPCO-Unicancer
- (2018) Florian Lemaitre et al. BULLETIN DU CANCER
- Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines – An Isobolographic Analysis
- (2015) Anna Wawruszak et al. PLoS One
- The role of taxanes in triple-negative breast cancer: literature review
- (2015) Giorgio Mustacchi et al. Drug Design Development and Therapy
- Frizzled 7 Expression Is Positively Regulated by SIRT1 and β-Catenin in Breast Cancer Cells
- (2014) Glenn E. Simmons et al. PLoS One
- High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
- (2013) Albrecht Stenzinger et al. BMC CANCER
- Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6Hz psychomotor seizure model – A type II isobolographic analysis
- (2013) Magdalena Florek-Luszczki et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models In Vitro and In Vivo
- (2013) S. Portmann et al. MOLECULAR CANCER THERAPEUTICS
- Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo
- (2013) Hui-Wen Chiu et al. PLoS One
- Epirubicin: Is it like doxorubicin in breast cancer? A clinical review
- (2012) Mustafa Khasraw et al. BREAST
- Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma
- (2012) Timothy B. Lautz et al. JOURNAL OF PEDIATRIC SURGERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started